Abstract
Immunization with a T-cell dependent antigen has been promoted as a reliable and sensitive tool for assessing the influence of putative immunotoxic exposures or agents on immune function. Keyhole limpet haemocyanin (KLH) is a very large, copper-containing protein molecule derived from the haemolymph of the inedible mollusc, Megathura crenulata. KLH is a highly immunogenic T-cell dependent antigen that is used increasingly in immunotoxicological studies, particularly in those involving animals. This report systematically reviews the human clinical studies that have used trans-cutaneous KLH immunization for assessment of the influence of various physiological and disease states and exposures on immune function over the last 20 years (1994-2013). These studies varied in their immunization protocols, formulation of KLH, dose, site and route of administration and immunoassay platforms developed to assess KLH-specific responses. KLH immunization has been well tolerated with only mild to moderate adverse effects reported. Though very promising as a model antigen candidate in immunotoxicology research, more work on standardizing immunization and immunoassay protocols is required.
Author supplied keywords
Cite
CITATION STYLE
Swaminathan, A., Lucas, R. M., Dear, K., & McMichael, A. J. (2014). Keyhole limpet haemocyanin - A model antigen for human immunotoxicological studies. British Journal of Clinical Pharmacology, 78(5), 1135–1142. https://doi.org/10.1111/bcp.12422
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.